, Singapore

Daily Markets Briefing: STI down 0.9%

Index showing signs of fatigue, says analyst.

OCBC Investment Research said:

Continued strength on Wall Street Friday should provide some relief to local sentiment, especially after last Friday’s 0.9% tumble.

However, note that we are starting to see some signs of fatigue; recent gains made by STI were on relatively thin volumes while gainers continued to lag losers.

As such, failure to retake the key 3400 resistance could still result in a deeper pullback for the STI.

Initial support likely found at 3317 (centre of Bollinger band), ahead of 3300.

IG markets Singapore noted:

In Asia, we are seeing the futures market in Hong Kong and Singapore trading higher and would expect the open to reflect this.

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare